These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 10545530)

  • 1. Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes.
    Macfarlane WM; Frayling TM; Ellard S; Evans JC; Allen LI; Bulman MP; Ayres S; Shepherd M; Clark P; Millward A; Demaine A; Wilkin T; Docherty K; Hattersley AT
    J Clin Invest; 1999 Nov; 104(9):R33-9. PubMed ID: 10545530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus.
    Hani EH; Stoffers DA; Chèvre JC; Durand E; Stanojevic V; Dina C; Habener JF; Froguel P
    J Clin Invest; 1999 Nov; 104(9):R41-8. PubMed ID: 10545531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Missense mutations in the human insulin promoter factor-1 gene are not a common cause of type 2 diabetes mellitus in Taiwan.
    Shiau MY; Huang CN; Liao JH; Chang YH
    J Endocrinol Invest; 2004 Dec; 27(11):1076-80. PubMed ID: 15754742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IPF-1/MODY4 gene missense mutation in an Italian family with type 2 and gestational diabetes.
    Gragnoli C; Stanojevic V; Gorini A; Von Preussenthal GM; Thomas MK; Habener JF
    Metabolism; 2005 Aug; 54(8):983-8. PubMed ID: 16092045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Missense mutations in the human insulin promoter factor-1 gene and their relation to maturity-onset diabetes of the young and late-onset type 2 diabetes mellitus in caucasians.
    Hansen L; Urioste S; Petersen HV; Jensen JN; Eiberg H; Barbetti F; Serup P; Hansen T; Pedersen O
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1323-6. PubMed ID: 10720084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional consequences of mutations in the MODY4 gene (IPF1) and coexistence with MODY3 mutations.
    Weng J; Macfarlane WM; Lehto M; Gu HF; Shepherd LM; Ivarsson SA; Wibell L; Smith T; Groop LC
    Diabetologia; 2001 Feb; 44(2):249-58. PubMed ID: 11270685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin promoter factor-1 gene mutation linked to early-onset type 2 diabetes mellitus directs expression of a dominant negative isoprotein.
    Stoffers DA; Stanojevic V; Habener JF
    J Clin Invest; 1998 Jul; 102(1):232-41. PubMed ID: 9649577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of maturity-onset diabetes of the young (MODY) genes in Thais with early-onset type 2 diabetes mellitus.
    Plengvidhya N; Boonyasrisawat W; Chongjaroen N; Jungtrakoon P; Sriussadaporn S; Vannaseang S; Banchuin N; Yenchitsomanus PT
    Clin Endocrinol (Oxf); 2009 Jun; 70(6):847-53. PubMed ID: 18811724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular background and clinical characteristics of autosomal dominant type 2 diabetes mellitus].
    Małecki M; Krolewski AS
    Przegl Lek; 2000; 57 Suppl 3():13-8. PubMed ID: 11293229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin promoter factor-1 mutations and diabetes in Trinidad: identification of a novel diabetes-associated mutation (E224K) in an Indo-Trinidadian family.
    Cockburn BN; Bermano G; Boodram LL; Teelucksingh S; Tsuchiya T; Mahabir D; Allan AB; Stein R; Docherty K; Bell GI
    J Clin Endocrinol Metab; 2004 Feb; 89(2):971-8. PubMed ID: 14764823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the insulin promoter factor-1 gene in late-onset type 2 diabetes mellitus.
    Reis AF; Ye WZ; Dubois-Laforgue D; Bellanné-Chantelot C; Timsit J; Velho G
    Eur J Endocrinol; 2000 Oct; 143(4):511-3. PubMed ID: 11022198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsense and missense mutations in the human hepatocyte nuclear factor-1 beta gene (TCF2) and their relation to type 2 diabetes in Japanese.
    Furuta H; Furuta M; Sanke T; Ekawa K; Hanabusa T; Nishi M; Sasaki H; Nanjo K
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3859-63. PubMed ID: 12161522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel Phe75fsdelT mutation in the hepatocyte nuclear factor-4alpha gene in a Danish pedigree with maturity-onset diabetes of the young.
    Møller AM; Dalgaard LT; Ambye L; Hansen L; Schmitz O; Hansen T; Pedersen O
    J Clin Endocrinol Metab; 1999 Jan; 84(1):367-9. PubMed ID: 9920109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An infant with combination gene mutations for Monogenic Diabetes of Youth (MODY) 2 and 4, presenting with Diabetes Mellitus Requiring Insulin (DMRI) at 8 months of age.
    Odem J; Munzinger E; Violand S; Van Morlan A; Rife D; Bachrach B
    Pediatr Diabetes; 2009 Dec; 10(8):550-3. PubMed ID: 19515026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel variants in the hepatocyte nuclear factor-1alpha gene in South Indian patients with maturity onset diabetes of young.
    Radha V; Ek J; Anuradha S; Hansen T; Pedersen O; Mohan V
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1959-65. PubMed ID: 19336507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A newly discovered role of transcription factors involved in pancreas development and the pathogenesis of diabetes mellitus.
    Habener JF; Stoffers DA
    Proc Assoc Am Physicians; 1998; 110(1):12-21. PubMed ID: 9460079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MODY in Iceland is associated with mutations in HNF-1alpha and a novel mutation in NeuroD1.
    Kristinsson SY; Thorolfsdottir ET; Talseth B; Steingrimsson E; Thorsson AV; Helgason T; Hreidarsson AB; Arngrimsson R
    Diabetologia; 2001 Nov; 44(11):2098-103. PubMed ID: 11719843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the aspartic acid to asparagine substitution at position 76 in the pancreas duodenum homeobox gene (PDX1) cause late-onset type 2 diabetes?
    Elbein SC; Karim MA
    Diabetes Care; 2004 Aug; 27(8):1968-73. PubMed ID: 15277425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different genes, different diabetes: lessons from maturity-onset diabetes of the young.
    Stride A; Hattersley AT
    Ann Med; 2002; 34(3):207-16. PubMed ID: 12173691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further evidence that mutations in INS can be a rare cause of Maturity-Onset Diabetes of the Young (MODY).
    Boesgaard TW; Pruhova S; Andersson EA; Cinek O; Obermannova B; Lauenborg J; Damm P; Bergholdt R; Pociot F; Pisinger C; Barbetti F; Lebl J; Pedersen O; Hansen T
    BMC Med Genet; 2010 Mar; 11():42. PubMed ID: 20226046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.